Molecular tools may improve risk assessment for oral lesions

This narrative review looked at how to manage oral potentially malignant disorders and oral squamous cell carcinoma. The authors noted that standard histopathological grading often lacks reliability. They also pointed out the inherent biological heterogeneity of these lesions makes simple grading difficult. Because of these issues, the review highlights a need for molecularly informed risk assessment in modern healthcare settings. No specific medications or interventions were tested in this review, so no safety data or side effects were reported. The study did not report a specific sample size or follow-up period. Readers should understand that this is a narrative review rather than a clinical trial with new data. The main takeaway is that current grading methods have limits. Doctors might consider molecular tools to help evaluate risk more accurately. This approach could help catch dangerous changes earlier or avoid unnecessary surgery. However, this review does not prove that molecular tests work better. More research is needed to confirm these ideas in real patients.